The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Sienna,
You have stated you own 100 quids worth of shares.
What I’m trying to say is why get so annoyed “****ging off BOD” for very little.
There more important things in life than worrying about £100
Wow
Sienna - for someone who has 100 quids worth of shares your seem to be really annoyed.
You constantly paste sheer waffle on here but have zero interest as a share holder doing any research or communicating with the company to get further understanding.
Just sell up your boring.
PLEASE READ POST FROM BIG DOUBLE - VERY IMPORTANT
If you have voted and not registered your vote at soloegm123@gmail.com please do so.
It is important we have an indication of votes registered so we can compare against the announced vote. I’m afraid I would reply on fair play with this Board.
Also it maybe necessary, it the short term, to pull all the support together to call a shareholders EGM. I will need as many contact details as possible in order to do this. I have over 100 already which is a great start.
The Board are obviously concerned as they would not have issued the RNS today. Don’t let them do more damage than they already have.
Well if the BOD have played there part and are reading this Board.
YOU WILL LOSE THE VOTE
Im sitting on a huge loss so would rather loose the lot and SCIR goes POP than let any other shareholder be conned by this BOD and there lifestyle Company.
Or and EGM and the BOD's are out of here.
Happened at VAL a few years back so very possible.
Vote NO already
Bunch of Clowns.
Vote in favour or we will dilute you severely
oh and btw the asset we have been saying has sooooo much potential and is amazing for over a decade. Well todays its not that great.
Clowns
Sienna you have £100 worth of shares.
Stop panicking you either loss 100 quid or gain Hundreds.
Not much risk Vs reward.
So chill.
You are staying this about the BOD - have you ever contacted them? Asked questions and have open dialogue? No thought not.
Voted Against
Businesses recruit when they have a demand due to existing or forthcoming contracts.
Thanks Woodstock- it’s a real shame tbh as I believe the tech in the right hands is very very useful and has value.
I hate the fact the BOD favour greed over fundamentally saving lives by enhancing the technology
RG funds Dmtr bod
BOD win with there fat fat salaries
RG rinses the system and investors
BOD win as does RG
It’s blatant to see.
Ask Mark Warne a question about his own company and I am pretty much certain he will be confused.
This isn’t a company
This company is dead for a number of years until the market And investors forget the company absolutely shafted there investors with a after hours Friday RNS disgusting cash raise of a 90+ % discount.
Mark Warne is on a disgusting salary plus his NED’s salaries. He is a crook
Doesn’t know his own business when questioned and asked - rather embarrassing tbh.
I had high hopes for DMTR - not a chance with this crook at the wheel
Black rock generate 22 billion in revenue per year and have a MC of 100 billion and have a great knowledge and background in this field which massive scope to expand
A 13D filing on Thursday disclosed a letter of intent that a portfolio company of BlackRock (NYSE: BLK) intends to make a proposal to transact with certain non-core assets of Tabula Rasa Healthcare (Nasdaq: TRHC).
Why it matters: Axios reported in late March that Tabula Rasa, working with Citigroup, was in advanced discussions regarding the sale of non-core assets, including PrescribeWellness.
Sources said then that conversations were being held with PE-backed strategics, with BlackRock-backed Transaction Data Systems among logical buyers of PrescribeWellness. TDS is a pharmacy technology company.
PrescribeWellness is a CRM (customer relationship management) tool that’s integrated with over 10,000 independent pharmacy operating systems.
State of play: Besides PE-backed portfolio companies, logical buyers would include Omnicell (NASDAQ: OMNCL), should it want to beef up its pharmacy-focused hardware and software presence within independent pharmacies.
Flashback: BlackRock’s perpetual capital fund agreed to acquire a majority interest in Transaction Data Systems in May 2021, with minority investor GTCR retaining a minority interest.
Context: Tabula Rasa has been outspoken about its plans to unload non-core assets to boost profitability, strengthen the balance sheet and become and remain cash flow positive by Q3.
The company in February disclosed letter of intent to sell DoseMeRx, a precision dosing tool used by pharmacists and physicians
Tabula Rasa bought PrescribeWellness less than three years ago for $150 million, but current price talk could not be determined.
BlackRock declined to comment, while Tabula Rasa did not immediately return a request for comment.
Obvs links to Val 201 , 301 , 401 and advisory board members.
But I can’t see it tbh
VAL would be a brucy bonus for PYC but definitely the pipeline will show far more Vaule
Well said.
Sienna - if you knew the company and the BOD and actually knew what role Harper had in the company then you would realise him leaving was extremely positive.
You really have no clue about this company and are merely gambling.
Good luck
On the signal comment if you believe this you are a fool.
I could have bought 1 share you could have bought 1 share or anyone else on the planet